| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5832106 | International Immunopharmacology | 2015 | 7 Pages | 
Abstract
												Thus, current results on bone properties of 16-week old female M3R-KO are related to postmenopausal osteoporotic phenotype. Stimulation and up-regulation of muscarinic acetylcholine receptor subtype M3 expression in osteoblasts might be a possible new option for prevention and therapy of osteoporotic fractures. Pharmacological interventions and the risk of side effects have to be determined in upcoming studies.
											Keywords
												DXATbPfTbThTbNCaHACTSKM3RSMITMDTRAPnAChRmAChRBMDRANKLROIBMCBCIP/NBTBV/TVALPAlkaline phosphataseOsteocyteTemBiomechanicsBone mineral densityTissue mineral densitydual-energy X-ray absorptiometryMinBending stiffnessminutesRankReal-time RT-PCRStructure model indextrabecular numbertrabecular thicknessBone mineral contentregion of interestThoracic VertebraeLumbar VertebraeTransmission electron microscopywild typehematoxylin-eosincalcium hydroxyapatitemuscarinic acetylcholine receptornicotinic acetylcholine receptorscholinergic receptorReceptor activator of nuclear factor κBReceptor activator of nuclear factor κB ligand
												Related Topics
												
													Life Sciences
													Immunology and Microbiology
													Immunology
												
											Authors
												Katrin Susanne Lips, Mathias Kneffel, Fee Willscheid, Frank Martin Mathies, Marian Kampschulte, Sonja Hartmann, Imke Panzer, Lutz Dürselen, Christian Heiss, Vivien Kauschke, 
											